2. Mergers and acquisitions are picking up: So far this year, buyouts have boosted several biotech stocks. Some standouts: Regulus Therapeutics went up 120%; 89bio went up 85%; Chimerix gained 69% and ...
Tobi is a crypto writer at Investopedia. He aims to simplify the complex concepts of blockchain and cryptocurrencies for the masses. Julie Bang/ Investopedia More people need better medicines, and ...
Biotechnology is the application of biological organisms, cells, or molecules to produce a product or service for the betterment of humankind. This area of study includes aspects of molecular biology, ...
But then came news of Merck 's ( MRK 1.32%) plans to acquire Cidara for $221.50 per share, or a 109% premium to its prior ...
Biotech Insiders Are Spending Billions. Trump Favors Less Oversight. One Biotech ETF Could Ride the Surge. The SPDR S&P ...
This transcript was prepared by a transcription service. This version may not be in its final form and may be updated. Alex Ossola: U.S. hiring slowed in January, but remained solid in the last jobs ...
Hosted on MSN
Is It Time to Buy Biotech Stocks?
In this podcast, Motley Fool analysts Tim Beyers and Karl Thiel discuss: To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. When you're ready to invest, check ...
Building an ethical business from day one can be a strategic advantage that attracts partners, talent and investors who care ...
Karen Marshall is the Executive Producer of GBH News' Morning Edition. Having alway dreamed of being an editor or writer, Karen got her start in radio at WROR in Boston as an intern, eventually ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback